Effects of platelet-rich plasma in a model of bovine endometrial inflammation in vitro by M.G. Marini et al.
RESEARCH Open Access
Effects of platelet-rich plasma in a model of
bovine endometrial inflammation in vitro
Maria Giovanna Marini1, Claudia Perrini2, Paola Esposti2, Bruna Corradetti1, Davide Bizzaro1, Pietro Riccaboni3,
Eleonora Fantinato3, Giuseppe Urbani4, Giorgio Gelati4, Fausto Cremonesi2 and Anna Lange-Consiglio2*
Abstract
Background: Endometritis reduces fertility and is responsible for major economic losses in beef and dairy
industries. The aim of this study was to evaluate an alternative therapy using platelet-rich plasma (PRP). PRP
was tested in vivo, after bovine intrauterine administration, and in vitro on endometrial cells.
Methods: Bovine endometrial cells were cultured until passage (P) 10 with 5 % or 10 % PRP. Effect of PRP on
endometrial cell proliferation and on the expression of genes [prostaglandin-endoperoxide synthase 2 (COX2), tumor
protein p53 (TP53), oestrogen receptors (ER-α and ER-β), progesterone receptor (PR) and c-Myc] involved in the regulation
of oestrus cycle and fetal-maternal interaction were evaluated. Moreover, to evaluate the ability of PRP to counteract
inflammation, 10 and 100 ng/ml of bacterial endotoxin lipopolysaccharide (LPS) were used to inflame endometrial cells in
vitro for 1, 6, 12, 24 and 48 h. The expression of genes such as interleukin 1β (IL-1β), interleukin-8 (IL-8), inducible nitric
oxide synthase (iNOS), prostaglandin-endoperoxide synthase 2 (COX2/PTGS2), and the release of PGE-2, IL-1β
and IL-8 were evaluated.
Results: In vivo treatment with PRP increased the detection of PR. In vitro, 5 % PRP at passage 5 increased
proliferation rate and induced a significant increase in the expression of all studied genes. Furthermore, the
results revealed that 10 ng/ml of LPS is the most effective dose to obtain an inflammatory response, and that
PRP treatment significantly down regulated the expression of pro-inflammatory genes.
Conclusion: This study lays the foundations for the potential treatment of endometritis with PRP in vivo.
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Background
The wall of the uterus consists of endometrium, myome-
trium and perimetrium (tunica serosa). The bovine
endometrium is a complex tissue that comprises the
tunica mucosa (lamina epithelialis and lamina propria
consisting of loose connective tissue) and the tunica sub-
mucosa of the uterus. In the lamina propria, neutrophils
and lymphocytes are commonly detectable. The endo-
metritis is characterized by an increase number of
inflammatory cells associated to epithelial erosion and/
or necrosis and diffuse oedema of endometrium [1].
Meta-analysis studies show that endometritis reduces
pregnancy rate by 16 % [2]. The economic losses related
to this disease are substantial and associated with a great
impact on the economy to drop in milk yield and calves,
and treatment costs [3]. Approximately, 80 % to 100 %
of cows have intrauterine bacterial contamination in the
first two weeks postpartum. In most cases, clinical dis-
ease does not develop, as the normal uterus is able to
clear a bacterial infection efficiently [4]. In 10 %-20 % of
cows, however, the infection is not controlled and may
lead to chronic uterine inflammation [1, 5]. It is com-
monly accepted that the development of uterine infec-
tion depends on the immune response of the cow, as
well as species and number of bacteria [1]. Economically,
important uterine diseases in cattle are commonly
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associated with bacterial infection by Escherichia coli,
Trueperella pyogenes, Fusobacterium necrophorum or Pre-
votella species [1, 5–8]. The most significant pathogenic
bacteria responsible for uterine infection are E. coli, which
produce an endotoxin lipopolysaccharide (LPS) that is
present in their cell wall.
Establishment of uterine bacterial infection may also
depend on metabolic disease, although the specific
mechanisms are still not clear or by endocrine envir-
onment, that affects the likelihood of bacteria elimin-
ation [9–11].
The inflammatory response is a complex process in-
volving many signalling cascades. In the genital tract, the
initial response of the endometrium against infection is
dependent on innate immunity and mucosal defence
systems [3, 12]. The uterine immune response is pro-
vided at the cellular level, by uterine leukocytes and
polymorphonuclear cells that are the cells phagocytizing
and clearing bacteria [13]. In horse, at the molecular
level, cytokines have a significant role in the recruitment
of inflammatory cells [14]. In cattle, interleukin-6 and
TNF-α stimulate the production of antimicrobial pep-
tides that assist in the elimination of pathogenic bacteria
[15, 16]. Moreover, bovine endometrial epithelial and
stromal cells can respond to bacterial LPS through the
Toll-like receptor (TLRs) [17]. Activated TLRs subse-
quently stimulate the production of pro-inflammatory
cytokines and chemokines [18].
Literature on the treatment of endometritis in cattle
is extensive and at times inconsistent. Specifically, uter-
ine disease treatments aim at reverting inflammatory
changes that impair fertility, whilst enhancing uterine
defence and repair [19]. In cows, many therapeutic
agents and procedures have been developed to treat
endometritis, including systemic or intrauterine admin-
istration of antibiotics [20–22], or administration of
PGF2α and its analogue [20–24]. The intrauterine infu-
sion of antiseptics (e.i. Lugol’s solution) has been tested
although side-effects on future fertility of the cows have
been reported [23, 25]. Furthermore, approaches using
proteolytic enzymes [21], administration of estradiol
[26, 27] or GnRH [28] have also been described. Even if
all these treatments show some effects on uterine heal-
ing, no definitive results can be extrapolated from pub-
lished clinical trials.
Platelet-rich plasma (PRP) is an emerging therapeutic
application in tissue regeneration and engineering due to
its enrichment in growth factors with mitogenic and
anti-inflammatory potential [29, 30]. In particular, PRP is
a concentration of platelets (3-5 fold the plasma baseline
level) containing transforming growth factor β1 (TGF-
β1) and TGF-β2, platelet derived growth factors (PDGF-
AA, PDGF-BB, PDGF-AB), insulin-like growth factor 1
(IGF-I), epidermal growth factor (EGF), vascular
endothelial growth factor (VEGF), fibroblast growth fac-
tor (FGF) and hepatocyte growth factor (HGF) that are
very important for regeneration processes. Indeed, these
growth factors act synergistically to increase the infil-
tration of neutrophils and macrophages, to promote
angiogenesis, fibroplasia, matrix deposition and, ultim-
ately, re-epithelialization, inducing the consequent
tissue regeneration [29]. Lastly, the presence of anti-
inflammatory molecules, including HGF [31] also
confers on PRP the ability to suppress inflammatory
process.
In this context, the specific aim of this study was to in-
vestigate the effect of PRP in vivo and in vitro, on a model
of healthy or LPS stressed bovine endometrial cells. In
vivo, the progesterone receptor (PR) expression was de-
tected immunohistochemically. The steroid hormone pro-
gesterone (P4) plays a key role in reproductive events
associated with establishment and maintenance of preg-
nancy. Conceptus growth and development require the
action of P4 on the uterus to regulate endometrial
function, including conceptus-maternal interactions,
pregnancy recognition, and uterine receptivity to im-
plantation [32]. Indeed, low P4 concentrations have
been implicated as a causative factor in the low preg-
nancy rates observed in high-yielding dairy cows [33].
In vitro, genes involved in the regulation of oestrous
cycle, in pro-inflammatory process and the release of
some cytokines were evaluated.
Methods
Experimental design
This study was based on three experiments. The first ex-
periment evaluated the endometrium histologically and
immunohistochemically, after in vivo PRP administra-
tion, using PR receptor as a marker of cell receptivity.
The second experiment evaluated the effect of a 5 % and
10 % concentration of PRP in culture medium, on in
vitro endometrial cell proliferation and on the expres-
sion of some genes involved in the regulation of oestrous
cycle and fetal-maternal interaction, to establish whether
it is able to improve the functions of this cell line. The
genes included prostaglandin-endoperoxide synthase 2
(COX2 or PTGS2), tumor protein p53 (TP53), oestrogen
receptors (ER-α and ER-β), progesterone receptor (PR)
and v-myc avian myelocytomatosis viral oncogene homo-
log (c-Myc). The third in vitro experiment evaluated the
ability of PRP to counteract an in vitro model of inflam-
mation by stressing endometrial cells with LPS at different
times and concentrations. Expression of pro-inflammatory
genes and release of some cytokines were evaluated.
Materials
Chemicals were obtained from Sigma-Aldrich Chemical
(Milan, Italy) unless otherwise specified. LPS was
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purchase by Sigma-Aldrich Chemical (E. coli 0:111B4;
L2630 catalog number). Tissue culture plastic dishes
were purchased from Euroclone (Milan, Italy).
Animals
All procedures were performed according to approved ani-
mal care and use protocols of the institutional ethics com-
mittee and to good veterinary practice for animal welfare as
to European directive 2010/63/UE. Written farmers’ con-
sent was obtained at the beginning of the study.
From a group of Holstein Friesian, animals at 150-180
days in milking belonging to a 180 cows dairy farm lo-
cated in North Italy, 14 cows bearing a well-developed
corpus luteum (CL) diagnosed by B-mode ultrasound
evaluation of the ovaries, were selected. They received
an i.m. luteolytic dose of PGF2α to synchronize the es-
trous cycle. All animals (n = 10) showed estrous signs in
the following 96 hours and at that time bacteriological
and cytological analyses, trans rectal and vaginal palpa-
tion, and sonography of the reproductive tract were con-
ducted to exclude genital diseases. These animals were
enrolled for the first study.
Endometrial samples for in vitro study were collected
from slaughtered bovines under legal regulations
Preparation of platelet-rich plasma
Collection of blood
Blood was obtained from two donor cows at forty days
in milking, as this is the period the circulating platelet
count is higher than other periods (data not shown).
These animals were in good health, free from infectious
diseases and they did not receive medication during the
previous two months. The collection of blood and the
preparation of PRP, with the method of double centrifu-
gation, were performed as reported by Lange-Consiglio
et al. [34]. After surgical scrub preparation of a few cen-
timeters of skin around the subcutaneous mammary
vein, 450 ml of blood was collected in ad hoc Terumo
blood bags (Terumo Srl, Rome, Italy) containing citrate-
phosphate-dextrose-adenine (CPDA-1) using the 16-
gauge needle provided with the bags. The bags were
transported at 4 °C to the laboratory within 2 h of
collection and immediately processed.
Double centrifugation method
All separation steps were performed under a horizontal
laminar flow hood in aseptic conditions. To prepare the
PRP, the blood was drawn into sterile Falcon tubes of
50 mL each (EuroClone SpA, Milan, Italy). The tubes
were centrifuged at 100 x g for 30 min at 4 °C. This
caused separation of the blood into three components:
red blood cells at the lowest level, “buffy coat” in the
middle layer, and platelet rich plasma (PRP) in the upper
layer. Afterward, the PRP was carefully aspirated and
distributed in new 50-ml tubes and centrifuged again at
1,500 x g for 10 min at 4 °C to obtain the platelet pellet
and the poor platelet plasma (PPP) on the upper layer.
Afterward, two-thirds of the volume of PPP was aspi-
rated for later use and the pellet mixed in the residual
PPP volume to allow for platelet count before the final
dilution with PPP to obtain PRP at a standard concen-
tration of 1 × 109 platelets/ml [34]. All platelet counts on
peripheral blood and PRP were performed using a HeCo
Vet automatic hematology analyzer (SEAC, Florence,
Italy). The total amount of PRP obtained for each donor
was aliquoted in 10 ml ready-to-use doses that were
stored in syringes. The syringes were then frozen at
−80 °C and thawed at 37 °C three times [35] to allow the
release of platelet-derived factors. The PRP was sub-
jected to aerobic and anaerobic bacteriological examin-
ation to verify its sterility. Syringes containing the PRP
dose were kept frozen at −20 °C until use.
Experiment 1: in vivo effect of intrauterine administration
of PRP
At day 4 post estrus, all previously selected animals were
checked by ultrasound for the presence of a newly
formed CL and were randomly divided in two groups.
Seven cows were treated with PRP while the other seven
animals were enrolled as control (CTR). Physiological
solution (0.9 % NaCl) was used as placebo for these lat-
ter. Ten ml of PRP or ten ml of physiological solution
were aseptically infused into the uterus by a disposable
sterile catheter included in a protective sheath guided
into the cervix by manipulation per rectum. To prevent
transfer of vaginal flora into the uterine lumen, the pro-
tective sheath was removed just after cervix penetration
and the catheter was hence introduced into corpus uteri
where PRP was infused.
Endometrial biopsy
Endometrial biopsies were collected using a stainless
steel Hauptner equine endometrial biopsy instrument as
previously described by Chapwanya et al. [15] and Katagiri
and Takahashi [36]. Samples were obtained just before
treatment at day 4 post estrus (T0) and 7-day post treat-
ment, that is at day 11 post estrus (T1). Briefly, after clean-
ing the base of tail, perineum and external genitalia,
animals were given caudal epidural anesthesia (4–5 ml
2 % of lidocaine). Afterwards, the biopsy instrument in-
cluded in a protective sheath was introduced into the
uterus through the cervix by manipulation per rectum.
Once the cervix was passed, and the protective sheath
ruptured, the tip of the biopsy instrument inside the
uterus was identified using the hand per rectum. Then,
with the help of the hand in the rectum, the medial uter-
ine wall was gently pressed into the instrument jaws and
biopsies were taken from the dorsomedial aspect of one
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horn just anterior to the bifurcation. Biopsies for histology
were gently removed from the biopsy instrument with a
fine gauge needle and transferred to a vial of fixation solu-
tion. All biopsies were processed by the same operator.
The samples were performed for histological and im-
munocytochemical studies.
Histological and immunohistochemical examinations
Samples were routinely formalin-fixed (10 % buffered
formalin) for 48-72 hours and paraffin-wax embedded.
Four-micrometer thick sections were stained with
hematoxylin and eosin (HE), while others were prepared
on poly-L-lysine–coated glass slides for immunohisto-
chemistry to detect the presence of PR.
The immunohistochemical staining of all samples was
performed using the avidin–biotin–peroxidase complex
procedure with a commercial immunoperoxidase kit
(Vectastain Standard Elite; Vector Laboratories, Inc.,
Burlingame, CA, USA).
Tissue sections were immersed in a pre-heated solu-
tion at 94 °C of Dewax and HIER Buffer H (Thermo
Fischer Scientific, Lab Vision Corporation, Fremont, CA,
USA) diluted 1:15 with deionized water for 40 minutes.
This solution is designed to simultaneously dewax and
perform heat induced epitope retrieval.
Endogenous peroxidase was blocked using 1 % hydro-
gen peroxide in Tris buffer for 45 min.
Sections were incubated for 18 hours at 4 °C with anti-
PR (Thermo Fischer Scientific, Lab Vision Corporation,
Fremont, CA, USA) mouse monoclonal antibodies di-
luted 1:400. After incubation with the secondary bio-
tinylated anti-mouse immunoglobulin (diluted 1:200;
Vector Laboratories, Inc.) for 30 min, the avidin–bio-
tin–peroxidase complex method (Vector Laboratories,
Inc.) was performed. Positive staining was visualized
with 3.3-diaminobenzidine-4 HCl (Vectastain, Vector
Laboratories, SK-4100) and nuclei were counterstained
with Mayer’s hematoxylin. Diluent negative control sec-
tions were produced by omission of the primary antibody.
Evaluation of histological and immunohistochemical data
Tissue samples were evaluated in order to assess the ab-
sence of pathological lesions.
The immunohistochemically stained tissue slides were
examined using standard light microscopy. Three ran-
domly selected areas were evaluated per section. The
staining results were independently scored semi quantita-
tively by different blinded operators at 400X magnifica-
tion. The results of PR protein expression were assessed
by categorizing immunoreaction of epithelial cells, muscu-
lar layer and glandular cells into five groups according to
the percentage of positive cells. These group were: 0) no
positive cells; 1) <1 % of positive cells; 2) from 1 % to
10 %; 3) from 11 % to 33 %; 4) from 34 % to 66 % and 5)
from 67 % to 100 % [37]. The intensity of labeling was
graded as: weak positive staining (W); moderate positive
staining (M); intense positive staining (I) and scored as
follows: W = 1, M = 2, I = 3. A total score was conferred
adding together the positive cells percentage score and the
intensity of immunolabeling score [37].
Experiment 2: effect of different concentrations of PRP on
in vitro endometrial cells proliferation and gene
expression
Tissue collection and cell isolation
Fresh bovine uteri were collected from three different
cows at the slaughterhouse intended for human con-
sumption and unrelated to our experiments. Samples
were obtained from healty normal-cycling cows at dies-
trus stage (middle-late luteal phase). Only uteri belong-
ing to cows with an obvious corpus luteum on the ovary
were used for endometrial fragment collection and ensu-
ing cell culture.
Endometrial samples were kept at 4 °C in saline
solution supplemented with 4 μg/ml amphotericin B,
100 IU/ml penicillin-100 μg/ml streptomycin and proc-
essed within 2 h. Endometrial stromal cells were ob-
tained according to the protocol described by Donofrio
et al., [38]. Briefly, the endometrium was digested in
25 ml of sterile filtered Hanks’ buffered salt solution
supplemented with 50 mg collagenase II, 100 mg bovine
serum albumin, and 10 mg DNase I for 90 minutes at
38.5 °C in a shaking bath. Then, cells were filtered with
an 80-μm filter, centrifuged at 300 x g for 10 minutes,
and washed twice in PBS. Before seeding, the total num-
ber of viable cells was evaluated by the exclusion
method staining with trypan blue and using a Bürker
chamber.
Cells expansion
A pool of endometrial stromal cells cultures from three
different cows was established in Dulbecco's Modified
Eagle's Medium high glucose (HG-DMEM) supple-
mented with 10 % FBS, 100 UI/ml penicillin–100 μg/ml
streptomycin, 0.25 mg/ml amphotericin B and 2 mM L-
glutamine (standard complete medium). For mainten-
ance of cultures, cells were plated in 75 cm2 flasks (SPL
Cell culture flask 70025) at up to 1x105 cells/cm2 and in-
cubated at 38.5 °C with 5 % CO2 in a humidified atmos-
phere. To remove non-adherent cells, the medium was
replaced for the first time after 48 h. Adherent cells were
detached with 0.05 % trypsin-EDTA just prior to reach-
ing confluence (80 %) and then reseeded for culture
maintenance at the density of 1x104 cells/cm2.
Proliferation studies
All data are representative of three independent
experiments.
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Doubling time (DT) DT for passages 1–10 (P1 and
P10) was assessed plating 9x103 cells into six-well tissue
culture plates. Every 4 days cells were trypsinized,
counted and reseeded at the same density. Mean DT
was calculated from day 0 to day 4. The DT value was
obtained for each passage according to the formula DT
= CT/CD, where CT represents the culture time and
CD = log (Nc/No)/log2 represents the number of cell
generations (Nc represents the number of cells at con-
fluence, No represents the number of seeded cells).
Growth curves To obtain growth curves at P1, P5 and
P10 endometrial cells were plated at the density of 9x103
cells into six-well tissue culture plates. Every two days,
over the 12 days of culture, cells from one well of each
plate were detached and counted.
In vitro effect of PRP on endometrial gene expression
In this study, culture medium was replaced for the first
time after 48 h to remove non-adherent cells and chan-
ged with complete standard medium supplemented with
two different concentrations of PRP, 5 % and 10 %, as a
FBS substitute. Control cells were grown in complete
standard medium supplemented with 10 % FBS. The
cells were expanded for 10 passages, which was the last
time point included in our study. Cells from each well
were then collected to evaluate mRNA expression of
genes involved in the regulation of oestrous cycle and
fetal-maternal interaction by quantitative real-time PCR.
The genes evaluated were prostaglandin-endoperoxide
synthase 2 (COX2), tumor protein p53 (TP53), oestrogen
receptors (ER-α and ER-β) and progesterone receptor
(PR). The expression of c-Myc was also evaluated.
Molecular characterization of endometrial cells was
performed at passages 1, 3, 5 and 10 by qualitative PCR.
Data were obtained from three replicates.
Experiment 3: In vitro effect of PRP after LPS treatment
on gene expression
P5 endometrial cells were plated in six well plates at a
density of 50,000 cells/well in DMEM standard complete
medium containing two different concentration of LPS,
10 ng/ml and 100 ng/ml. Evaluation of the expression of
genes involved in inflammation was performed at 1, 6,
12, 24 and 48 h. The LPS concentrations were chosen
on the base of results of Herath et al. [39] that demon-
strated level of LPS around 100 ng/ml in cows with clin-
ical endometritis. Supernatants were collected and
stored at -20 °C until being used for ELISA to measure
PGE-2, IL-1β and IL-8.
To study the in vitro effect of PRP in cells inflammed
with LPS, endometrial cells were treated with 10 ng/ml
LPS and 5 % PRP for 1, 6, 12, 24 and 48 h. At each time
point, the expression of same genes was analyzed. Data
were obtained from three replicates.
Molecular characterization
Total RNA was extracted from endometrial cells using
TRI Reagent Solution (Life Technologies, Monza, Italy).
Samples were then treated with DNase in order to elim-
inate DNA contamination. RNA concentration and pur-
ity were measured by Nanodrop Spectrophotometry
(NanodropH ND1000). The quality and integrity of the
total RNA extracted were verified by electrophoresis on
a 1.5 % (w/v) agarose gel. The cDNA was synthesized
from total RNA (200 ng) using the PrimeScript RT re-
agent Kit (Takara Bio). Gene expression evaluation was
performed using bovine specific sequences. Oligonucleo-
tide primers were designed using open source PerlPri-
mer software v. 1.1.17 based on available NCBI Bos
taurus sequences or on mammal multi-aligned se-
quences. Primers were designed across an exon–exon
junction in order to eliminate genomic DNA amplifica-
tion and their sequence conditions and the references
used are shown in Table 1.
Qualitative PCR analysis was performed in a 25 μl
final volume with Taq DNA Polymerase recombinant
commercial kit (Invitrogen Life Technologies) under
the following conditions: initial denaturation at 94 °C
for 2 minutes, 32 cycles at 94 °C for 30 seconds
(denaturation), 55–60 °C for 30 seconds (annealing),
72 °C for 30 seconds (elongation) and final elongation
at 72 °C for 10 minutes. For conventional PCR,
primers were used at 200 nM final concentrations.
Quantitative PCRs were performed with SYBR green
method in a MyiQ iCycler thermal cycler (Biorad).
PCR reactions were carried out in triplicate for each
sample. The reactions were set on a strip in a final
volume of 25 μl by mixing, for each sample, 1 μl of
cDNA, 12.5 μl of 2X concentrated SYBR Premix Ex
Taq II (Takara Bio) containing SYBR Green as a
fluorescent intercalating agent, 0.2 μg forward primer,
0.2 μg of reverse primer and MQ water. PCR efficien-
cies were tested and found to be close to 1. The ther-
mal profile for all reactions was 30 seconds at 95 °C
and then 40 cycles of 5 seconds at 95 °C, 30 seconds
at 60 °C. Fluorescence monitoring occurred at the
end of each cycle. Efficiency of amplification for each
primer was monitored through the analysis of serial
dilution. Additional dissociation curve analysis was
performed and in all cases showed a single peak. The
data thus obtained were analyzed using the iQ5 op-
tical system software version 2.0 (BioRad). The
expression of each gene was normalized to the refer-
ence gene glyceraldehyde-3-phosphate dehydrogenase
(GAPDH) (internal control) in order to standardize
the results by eliminating variation in cDNA quantity.
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Such gene was identified among others used as
endogenous control genes based on previous studies
focusing on endometrial gene expression [40]. Relative
gene expressions were presented with the 2−ΔΔCt
method [41].
Protein release by ELISA
Protein release (PGE-2, IL-1β and IL-8) was measured in
cell-free supernatants obtained by centrifugation at 250
x g for 5 min and stored at −80 °C until measurement.
Protein production was assessed according to the man-
ufacturers’ instructions (Bovine PGE-2 MBS737103,
MyBioSource; Bovine IL-1β Screening Set ESS0027,
Thermo Fisher Scientific; CXCL8/IL-8 DuoSet DY208,
R&D Systems). The Human CXCL8/IL-8 DuoSet was
previously validated for measurement of bovine IL-8
[42]. The limits of detection for PGE-2, IL-ß and IL-8
were 1.0, 20.1 and 14.3 pg/ml, respectively.
Results are expressed in pg/ml.
Statistical analysis
Statistical analysis was performed using GraphPad Instat
Software version 3.00 for Windows (La Jolla, CA, US).
For proliferation data, three replicates for each experiment
were performed. Results are reported as mean ± standard
deviation (SD). One-way analysis of variance (ANOVA)
for multiple comparisons by Student-Newman-Keuls mul-
tiple comparison tests was used.
Immunohistochemical data were analyzed by unpaired
Student's t-test.
For cytokines, statistical differences were determined
using ANOVA followed by Dunnett's multiple compari-
son test, the Tukey–Kramer multiple comparisons test
or unpaired t test.
Differences were considered statistically significant for
P values < 0.05.
For quantitative PCR data, non-parametric tests were
used. The Mann-Whitney U-test was employed to com-
pare two groups (treated vs untreated). Results were
considered significant if the value of P was < 0.01.
Results
Experiment 1: in vivo effectiveness of intrauterine
administration of PRP
Histological examination
No pathological alterations were detected in any of the
examined biopsies. All the samples were covered by a
columnar simple epithelial monolayer. A moderately
large amount of uterine glands was dispersed in the
stroma. Scattered rare lymphocytes were also detectable
in the stroma. Neither fibrosis nor hemorrhages were
present.
Immunohistochemical evaluation
Positive nuclei to PR were brown-stained, while negative
nuclei were blue stained by hematoxylin counterstain.
Diluent negative controls showed no immunoreaction.
The PR immunoreactivity was evaluated separately in
the surface epithelial cells, glandular epithelium and
smooth muscle cells. The total scores are listed in Table 2.
Table 1 Oligonucleotide sequences used for RT-PCR analysis
Marker Forward 5'-3' Reverse 5'-3' T annealing bp
Interleukin-1β
(IL-1β)
TGCAGCTGGAGGAAGTAGAC GTCGGGCATGGATCAGACAA 60 338
Interleukin 8
(IL-8)
ACATACCCTGCCACAAGGC TGGGGACTGCTCTTCCCTCT 57 146
Inducible nitric oxide synthase (iNOS) GGACCTCAACAAAGCCCTGA CCTTGACCCAATAGCTGCCA 60 293
Prostaglandin-endoperoxide synthase 2
(COX2)
CATGGGTGTGAAAGGGAGGAA AAAGACGTCAGGCAGAAGGG 60 700
Tumor protein p53
(TP53)
CCTAGGAGCACTAAGCGAGC GCCCCTCTCTCTTGAGCATT 55 268
Oestrogen receptor alpha
(ERα)
AGGGAAGCTCCTATTTGCTCC CGGTGGATGTGGTCCTTCTCT 55 234
Oestrogen receptor beta
(ERβ)
GCTTCGTGGAGCTCAGCCTG AGGATCATGGCCTTGACACAG 55 262
Progesterone receptor
(PR)
GAGAGCTCATCAAGGCAATTGG CACCATCCCTGCCAATATCTTG 55 227
v-myc avian myelocytomatosis viral oncogene homolog
(c-Myc)
GCGCCGCATTCGCGAAACTT TGAGGGGCATCGCTGCAAGC 58 °C 214
Glyceraldehyde-3-phosphate dehydrogenase
(GAPDH)
ATGAGATCAAGAAGGTGGTG CCAAATTCATTGTCGTACCAG 60 190
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PR expression has been detected in all these uterine
compartments (Fig. 1). Treated animals in T1 showed
the highest PR receptor score in glandular epithelium
and smooth muscle cells compared to T0 (P < 0.05). In
T1 control animals, glandular epithelium and smooth
muscle cells obtained the same high average score that
is not statistically different compared to T0 (P > 0.05).
Experiment 2: effect of different percentages of PRP on in
vitro endometrial cells proliferation and gene expression
Cells isolation and expansion
Cells were selected on their ability to adhere to plastic.
For endometrial cells, initial viability was >80 %. Cells
displayed the typical fibroblast-like morphology (Fig. 2a).
The molecular biology study on the isolated cells con-
firmed their endometrial nature due to the expression of
ER-α, ER-β, PR and TP53 (Fig. 2b).
Proliferation studies
The DT value at P1 and P2 were similar between the
cells grown in presence of 5 % PRP, 10 % PRP and 10 %
FBS. After P2, for endometrial cells grown in presence
of 5 % PRP, the proliferative ability increased until P5
while for cells grown in presence of 10 % PRP, the prolif-
erative ability decreased and then remained constant
until P10. No difference in the DT value for endometrial
cells grown in presence of 10 % FBS were found over
the passages studied (Fig. 3a). The mean DT value for
endometrial cells grown in presence of 5 % PRP was
1.96 ± 0.31 days, while it was 4.64 ± 1.52 and 2.20 ±
0.22 days for endometrial cells grown with 10 % PRP
and FBS 10 %, respectively.
Endometrial cells cultured with 5 % of PRP, at P1
showed a growth curve with an initial lag phase of 2 days
and a subsequent long log phase of 8 days. At P5, endo-
metrial cells demonstrated a growth curve with an initial
lag phase similar to that observed for P1, continues with
a log phase of 4 days followed by a stationary phase of
4 days. Finally, after 10 days in culture, a death phase
was observed. At P10, endometrial cells showed a
growth curve with an initial lag phase longer than that
registered for endometrial cells at P5 (2-8 days) and sub-
sequent log phase shorter than that observed for P5
(2 days) (Fig. 3b).
In vitro effect of PRP on endometrial gene expression
Endometrial cells were cultured in presence of two dif-
ferent concentrations of PRP (5 % and 10 %) until pas-
sage 10, and mRNA expression of genes involved in the
regulation of oestrous cycle and fetal-maternal inter-
action was measured by quantitative PCR. PRP 5 % at
P5 had a significant effect on the expression of endo-
metrial genes when compared to the expression levels
of untreated cells (Fig. 4a-f ). The results showed a
statistically significant increase (P < 0.01) in the ex-
pression of all studied genes at P5 in cells cultured in
Table 2 Total score for PGR expression in bovine according to the surface epithelial cells, glandular epithelium and smooth muscle
cells
Surface epithelium Glandular epithelium Smooth muscle
Subject T0 T1 T0 T1 T0 T1
SALINE CTR 2 5 3.5 8 5 3 4.5
4 8 4 8 8 6.5 6.5
8 3 4 3 8 4 7.5
9 8 7.5 7.5 8 5.5 7.5
10 3 2 4 4 4 7
11 4 4 5 4 5 4.5
14 4 4 6 7 6 4
Average score 5.0±2.2a 4.1±1.7a 5.9±2.0a 6.3±1.9a 4.4±1.1a 5.8±1.66a
PRP 1 5 3.5 5.5 6.5 4 7.5
3 3.5 0 4.5 7 2.5 6.5
5 2 6.5 3.5 8 2.5 7
6 8 8 7.5 8 8 7.5
7 7.5 8 8 8 6 6.5
12 5 5 6 7 3 7
13 4 6 5 7 5 6.5
Average score 5.0±2.1a 5.3±2.8a 5.7±1.6a 7.4±0.6b 4.4±2a 6.9±0.4b
Legend: average score represent mean ± standard deviation. Different small letters superscripts (a,b) indicate statistically different comparisons (P<0.05) between
T0 and T1
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presence of 5 % PRP compared to 10 % PRP or 10 %
FBS. In particular, ER-α expression increased 9-fold
(±0.66), ER-β expression increased 260-fold (±6.8), PR
expression increased 5.44-fold (±0.85), TP53 expres-
sion increased 5.56-fold (±0.52) and COX2 expression
increased 15.74-fold (±0.78). The expression of c-Myc
increased of 22-fold (±0.24). At P10, a decrease in the
expression of all the evaluated genes was observed,
with the only exception on TP53, whose expression
remains constant.
Experiment 3: in vitro effect of PRP after LPS treatment on
gene expression
Endometrial cells at P5 were cultured with or without
10 ng/ml or 100 ng/ml LPS for 1, 6, 12, 24, and 48 h,
and mRNA expression of pro-inflammatory genes was
evaluated by qPCR. The results are summarized in
Fig. 5a,c,e,g for 10 ng/ml and Fig. 5b,d,f,h for 100 ng/ml.
Treatment with PRP did not alter GAPDH mRNA ex-
pression, which was included as a reference gene. The
results revealed that the 10 ng/ml concentration of LPS
between 1 h and 12 h is the most effective dose to in-
duce an over-expression of pro-inflammatory genes in
bovine endometrial cells.
A significant increased (P < 0.01) expression of IL-1β
(18.65 ± 0.32), iNOS (208.17 ± 0.18) and COX2 (99.84 ±
0.31) was observed immediately (1 h) after LPS treat-
ment compared to untreated cells. Expression of IL-8
was significantly higher (P < 0.01) at 6 h and 12 h (10.55
± 0.29 and 10.22 ± 0.12 respectively) after LPS treatment
compared to untreated cells. Within 48 h, all genes
returned nearly to baseline.
The PRP treatment had a significant effect (P < 0.01)
on the endometrial gene expression of these genes when
Fig. 1 Immunohistochemical PR expression in uterine biopsies (20x, Haematoxylin counterstain). Figures in the left column are of PRP group treated at T0
while in the right column are of PRP group treated at T1. Arrows show the following results. Uterine surface epithelium showing: (a) weak positivity
involving scattered cells (score W1); (b) and marked positivity in the majority of the epithelial cells (score I5). Glandular epithelium with (c)
weak and diffuse immunostaining (score W4); (d) intense and diffuse imunostaining scored as I5. Smooth muscle cells with (e) moderate and
diffuse immunolabeling (score M5). The same score is detectable in the close glandular epithelium. (f) Intense and diffuse
immunohistochemical expression in smooth muscle cells (score I5)
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compared to the levels of expression found in the LPS
(10 ng/ml) treated cells (Fig. 6a-d). The mRNA expres-
sion of the pro-inflammatory cytokine IL-1β was found
significantly lower compared to untreated cells, passing
from 18.65 ± 0.32 to 0.59 ± 0.16 (P < 0.01), immediately
1 h after PRP treatment. The mRNA expression of the
pro-inflammatory chemokine IL-8 was significantly lower
(P < 0.01) with values decreasing at 1 h, 6 h and 12 h after
PRP treatment to 0.33 ± 0.14, 1.37 ± 0.31 and 2.23 ± 0.16,
respectively, compared to untreated cells. A significant re-
duction (P < 0.01) in the expression levels of iNOS (from
208.17 ± 0.18 it fell to 1.66 ± 0.04) and COX2 (from 99.84
± 0.31 it fell to 7 ± 0.07) was found compared to untreated
cells 1 h after treatment with PRP.
Protein release
The results of the release of PGE-2 for endometrial cells
treated by PRP at P5 are shown graphically in Fig. 7a.
The release of PGE-2, IL-1β and IL-8 by endometrial
cells stimulated with 10 ng/ml of LPS and treated with
5 % PRP at different time (1, 6, 12, 24 and 48 h) are
shown graphically in Fig. 7 b,c,d). In endometrial cells
(CTR), the concentrations of IL-1β and IL-8 were below
the limits of detection of the assay. The endometrial cells
responded to 5 % of PRP with release of 5000 ± 480 pg/ml
of PGE-2 that is statistically different (P < 0.05) compared
to CTR (330 ± 30 pg/ml). The treatment with 10 ng/ml of
LPS induced release of PGE-2 and IL-1β at 1 h (30000 ±
2490 and 2500 ± 220 pg/ml, respectively). The greater
release of IL-8 was at 6 h (150 ± 13 ng/ml).
The PRP was able to counteract the action of LPS and
significantly (P < 0.05) decreased the production of PGE-
2, IL-1β and IL-8 mainly between the first and the 24a h.
Discussion
In the present study, the effect of PRP has been investi-
gated in vivo on healthy animals (without endometrial
infection) and in an in vitro model where bovine endo-
metrial cells were stressed with LPS. After in vivo appli-
cation, our results delineate a trend showing that, in
vivo, PR expression was detected with a similar average
score in all the animals at T0. At T1 in epithelial cells,
PR average scores in control and PRP animals remain
unchanged. In glandular epithelium and smooth muscle
cells, at T1, PR expression increases in PRP animals.
These results have to be further explored but may indi-
cate that PRP might be helpful in maintaining and/or in-
creasing the number of progesterone receptors in
uterine tissues. In our in vitro experiment, bovine endo-
metrial cells were cultured with two different concentra-
tions of PRP (5 % and 10 %) and mRNA levels of
different genes were quantified and compared to control
cells, cultured with 10 % FBS only. Various research
groups have studied the use of PRP as a supplement of
cell culture [43–45] demonstrating that PRP increases
cell proliferation. PRP confirmed this effect also on endo-
metrial cells, mainly at the concentration of 5 %. This con-
centration of PRP sustained the shortest population
doubling time at P5 while the highest concentration
(10 %) inhibited proliferation rate, leading to speculate
that this effect may be due to an excess of growth factors.
This data was confirmed by growth curve study with 5 %
of PRP at different passages. According to this, at P5, 5 %
of PRP induced an intensive endometrial cells prolifera-
tion. Regarding gene expression, the presence of 5 % of
PRP at P5 induced also an up-regulation of the expression
of COX2, TP53, ER-α, ER-β and PR. To test the release of
Fig. 2 (a) Cell morphology. Monolayer of endometrial cells. Scale bar: 20 μM. Magnification 20X. (b) Molecular characterization of endometrial cells at
diestrus stage. Qualitative PCR analysis for the expression of genes that influencing pre-implantation conceptus development (ERα, ERβ and PR)
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some proteins, we evaluated the secretion of prostaglandin
E2 (PGE2). Indeed, it is known that in the bovine uterus,
COX2 converts arachidonic acid to prostaglandin H2,
which is then converted, by PGE synthase and PGF syn-
thase, to PGE-2 [46]. In these cells, PGE-2 production was
modulated in parallel with COX2 expression in all condi-
tions. This is the first study reporting the effects of PRP
on the proliferation and gene expression of bovine endo-
metrial cells in vitro and further studies are required to
elucidate the mechanisms through which the PRP up-
regulates these genes. Although, the molecular mecha-
nisms involved in this up-regulation are not clear, is con-
ceivable that PRP-derived growth factors play an
important role. Indeed, the expression of c-Myc, that was
up-regulated in this study and which is involved in cell
proliferation and growth, is activated by EGF that is a
component of PRP [29].
In our study, we even further tested the hypothesis
that PRP has anti-inflammatory properties and is able to
influence gene expression of pro-inflammatory factors in
an in vitro model of inflammation. To develop an in
vitro cell culture system with stressed cells and to study
gene response, endometrial cells were exposed to the
bacterial endotoxin LPS before and after the treatment
with PRP. Exposure of endometrial cells to 10 ng/ml LPS
resulted in marked changes in the expression of pro-
inflammatory genes that was reduced by the addition of
5 % of PRP. The presence of PRP ameliorated the LPS-
induced molecular changes in endometrial cells as
they increased the levels of gene expression of IL-1β,
IL-8, iNOS and COX2 expression. In parallel with
gene expression, the release of some proteins was
studied confirming the observations regarding gene
regulations. LPS demonstrates to be capable of
Fig. 3 Proliferation studies. (a) Doubling time at different passages during cell culture in different culture conditions (5 % PRP and 10 % FBS). (b)
Growth curve at P1, P5 and P10 for endometrial cells cultured with 5 % PRP
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inducing the release of PGE-2, IL-1β and IL-8 whose
pick were obtained 1 h and 12-24 h, after stimulation
with LPS. PRP reduce the release of these proteins-
and the maximum modulatory activity was observed
immediately after 1 h for PGE-2 and IL-1β, and be-
tween 12 h and 24 h for IL-8. Therefore, our results
indicated consistent anti-inflammatory effect of PRP.
How can we explain these results? Recent literature
demonstrates the healing potential of autologous
platelet-rich plasma in human medicine, including max-
illofacial surgery, dental implant surgery, orthopedic sur-
gery, bone reconstruction, muscle and tendon repair,
reversal of skin ulcers, retinal hole repair in eye surgery,
and cosmetic surgery [29]. In veterinary medicine, little
Fig. 4 Quantitative PCR analysis for the expression of genes involved in the regulation of oestrus cycle and fetal-maternal interaction like: (a, b)
oestrogen receptors (ERα and ERβ), (c) c-Myc, (d) progesterone receptor (PR), (e) tumor protein p53 (TP53), and (f) prostaglandin-endoperoxide
synthase 2 (COX2) in cells cultured in presence of 5 % PRP. Also the expression of is reported. Expression levels normalized to the reference gene.
Data are represented as fold-change compared with expression observed in cells cultured in presence of 10 % FBS. Values are mean ± SD (n = 3).
Asterisk depict highly significant (*, P < 0.01) differences compared to cells cultured in presence of 10 % FBS
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Fig. 5 Quantitative PCR analysis for the expression of pro-inflammatory markers such as IL-1β, IL-8, iNOS and COX2 in cells cultured in presence of 10
(a, c, e, g) or 100 ng/ml LPS (b, d, f, h). Expression levels normalized to the reference gene GAPDH. Data are represented as fold-change compared with
expression observed in untreated cells. Values are mean ± SD (n = 3). Asterisk depict highly significant (*, P< 0.01) differences compared to untreated cells
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clinical information exists about its application. PRP is
mainly used for equine tendon repair [47] although its
application has also been reported for intestinal wound
healing in pigs [48] and for the treatment of a large cuta-
neous lesion in a dog [49]. Recently, our group has
proposed its use as an alternative therapy for bovine
mastitis and for repeat breeder cows syndrome, showing
promising results [32, 50]. Indeed, in acute mastitis, the
treatment with only PRP did not show statistically
significant differences compared to antibiotic alone or
treatment with PRP combined to antibiotic, but it was
better than the use of only antibiotic for chronic mastitis
[32]. In repeat breeder treatment, after intrauterine ad-
ministration of PRP the percentage of pregnant cows
was 70 % compared to control group, treated with
physiological solution, where the rate was 33.33 %.
Moreover, immunohistochemical study, by the nuclear
antigen Ki-67, a marker of cell proliferation, showed
more proliferating nuclei in the treated uterine horn,
after three days of administration, compared to the
control one [50]. In tissues with a high proliferative rate,
Ki-67 is expressed in all cell cycle phases except for the
resting or G0 phases [51, 52] and reaches a maximum
level during G2 and M [53]. Since Ki-67 was significantly
more expressed in uterine horns treated with PRP,
Lange-Consiglio et al. [50] supposed that the growth
factors released by platelets in the PRP might have
had an effect on endometrial cell proliferation. In-
deed, in all treated horns there were statistically more
proliferating nuclei compared to the controls. Also in
our in vitro study, PRP induce cell proliferation con-
firming these previous results [50], but a longer in
vitro culture time (P5) is necessary to stimulate a
good proliferation rate. It is difficult to explain the
different times of PRP efficacy between in vivo and in
vitro study, probably they are mainly due to the dif-
ferent doses used.
After the study with PRP on repeat breeder cows, our
group tried to test the effect of PRP on in vitro endomet-
rial stressed cells by LPS. Results showed that LPS
Fig. 6 Quantitative PCR analysis for the expression of pro-inflammatory markers such as IL-1β, IL-8, iNOS and COX2 in cells cultured in presence of 10
ng/ml of LPS and 5 % PRP. Expression levels normalized to the reference gene GAPDH. Data are represented as fold-change compared with expression
observed in untreated cells (CTR). Values are mean ± SD (n= 3). Asterisk depict highly significant (*, P < 0.01) differences compared to untreated cells
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provoked a rapid increase in endometrial mRNA expres-
sion and release of IL-1β and IL-8. Previous studies have
shown that bovine endometrium expresses the TLR-4/
CD14/MD-2 receptor complex in both epithelial and
stromal cells [17, 18, 54]. This is a key component of the
innate immune system, which is necessary to detect LPS.
Subsequent activation of TLR4 triggers the production
of cytokines, particularly IL-1β and chemokine IL-8 in
bovine endometrium. Accordingly, after LPS treatment,
we found an immediate rapid rise in IL-1β expression,
which had already peaked by 1 h, and had been followed
by a rise in IL-8 expression, with a significant up-
regulation at 6 h and 12 h. These waves of cytokine gene
activation, short for IL-1β and prolonged for IL-8 until
12 h, are supported by data of DeForge and Remick [55]
that studied the kinetics of these cytokines in LPS-
stimulated human whole blood as an ex vivo model of
sepsis. LPS also induces an inflammatory response char-
acterized by the increased expression of iNOS and
COX2 and stimulates the secretion of PGE, as demon-
strated also by Herath et al. [56]. Prostaglandins, pro-
duced by the uterine endometrium, have multiple roles
in endometrial function [46]. Indeed, they are key regu-
lators of several reproductive events, including estrous
cycle, implantation, pregnancy maintenance and
parturition. The release of PGE-2 induced by 5 % of PRP
could support these events. In addition, PGE has an im-
portant role in the mammalian immune response, acting
through prostaglandin E receptors 2 and 4 (PTGER2
and PTGER4) to control inflammation [3]. Instead, the
intensive LPS-induced PGE secretion by endometrial
cells may impair fertility. In fact, this has been suggested
as a pathogenic mechanism after uterine bacterial infec-
tion, which could result in an extended luteal phase and
thus contribute to an impaired reproductive perform-
ance. According to this, COX2 was greatly up-regulated
in the present study by LPS. Regarding the inducible
iNOS, it is the main isoenzyme governing the produc-
tion of NO, and it is considered an important mediator
of cellular interactions and a potent regulator of many
local processes [57]. iNOS is typically expressed at the
sites of inflammation, produces large amounts of NO for
a prolonged time and is usually related to the activation
of pro-inflammatory macrophages [58]. In this context,
our findings showed a significantly higher expression of
iNOS in cells cultured in presence of LPS. This gene
returned nearly to baseline within 48 h, supporting the
idea that the inflammatory process is controlled by nega-
tive feedback regulation in order to eliminate excessive
tissue inflammation and damage [59].
Fig. 7 Effect of 5 % PRP at P5 on release of PGE-2 (a) and effect of LPS and PRP on release of PGE-2 (b), IL-1β (c) and IL-8 (d) in endometrial cells. Each
value represents the mean ± SD of three samples. Values labeled with asterisk are statistically different (P < 0.05) compared to untreated cells (CTR)
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The treatment with 5 % of PRP, after LPS action, down-
regulated the expression of all pro-inflammatory genes.
The inhibition of NF-kB (nuclear factor kappa-light-
chain-enhancer of activated B cells) activation could be a
possible mechanism through which PRP exerted these
anti-inflammatory effects. Within mammalian cells, in-
cluding endometrial cells, NF-kB is present in an inactive
status [60]. It regulates more than 150 genes, including
those involved in inflammation and other immune re-
sponses [61]. Upon phosphorylation, it translocates into
the nucleus [62] by the interaction of specific receptors on
the surface of a cell, and it triggers the inflammatory cas-
cade. In particular, LPS is reported to bind the surface
antigen CD44 and induce the translocation of the phos-
phorylated Nf-kB to the nuclei leading to the increase
of pro-inflammatory gene levels [63]. Numerous stud-
ies demonstrated that PRP inhibited the translocation
of NF-kB to the nucleus [31, 64]. Between different
growth factors, indeed, the HGF is described to dis-
rupt the transactivacting activity of NF-kB, with its
retention in the cytosol [31].
Based on these results, it would be interesting to ex-
plore the mechanisms through which the PRP induces
up-regulation of COX2, TP53, ER-α, ER-β and PR genes
and to perform in vivo investigation on the potential ap-
plication of PRP in the treatment of bovine endometritis.
Indeed, considering the results obtained in our in vivo
and in vitro studies, it might be possible to envisage
treatment of endometritis with PRP combined with ad-
ministration of exogenous P4. This combination, using
intravaginal P4 devices, may improve the fertility in
bovine with inadequate circulating P4 concentrations. In
this way, at the same time, it would be possible to in-
crease circulating P4 concentration and endometrial PR.
Conclusions
Although this study is performed on an in vitro model, our
data indicates that PRP have strong effects on endometrial
cells determining high proliferation rate and up-regulation
of genes that play an important role in reproduction. The
mechanisms through which the PRP up-regulates these
genes is not yet clear, but it is conceivable that its growth
factors are involved in these mechanisms. The results of
the current investigation demonstrated that PRP is capable
of effectively decrease gene expression of pro-inflammatory
factors IL-1β, I-L8, COX2 and iNOS after stimulation by
LPS, prospecting its possible use in regenerative therapy in
in vivo endometritis.
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